Zhou et al. showed that in a mouse CKD model, the PRMT3 inhibitor SGC707 alleviates VC and inhibits glycolysis, while knockdown of PRMT3 effectively mitigates calcification through the HIF-1α-mediated metabolic pathway [77]. The gene discussed is PRMT3; the disease is chronic kidney disease.